Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages

  Jabłońska, Agnieszka ^a   Paradowska, Edyta ^a   Studzińska, Mirosława ^a   Suski, Patrycja ^a   Nowakowska, Dorota ^b,c   Wiśniewska Ligier, Małgorzata ^c   Woźniakowska Gesicka, Teresa ^c   Wilczyński, Jan ^b,c   Leśnikowski, Zbigniew J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Cytomegalovirus; Single nucleotide polymorphism; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CODON;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE DOSAGE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; YOUNG ADULT; ALLELE; AMINO ACID SUBSTITUTION; CODON; CYTOMEGALOVIRUS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; INFANT; NEWBORN; RISK; RISK FACTOR; VIROLOGY;

ADULT; AGED; ALLELES; AMINO ACID SUBSTITUTION; CODON; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VIRAL LOAD; YOUNG ADULT;

EID: 84901644335     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.04.001     Document Type: Article

References (44)

1. Boehme K.W., Guerrero M., Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 2006, 177:7094-7102.
2. Brown R.A., Gralewski J.H., Razonable R.R. The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus. Clin Infect Dis 2009, 49:e96-e99.
3. Yew K.H., Carpenter C., Duncan R.S., Harrison C.J. Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression. PLoS One 2012, 7:e44500.
4. Arcangeletti M.C., Germini D., Rodighiero I., Mirandola P., De Conto F., Medici M.C., et al. Toll-like receptor 4 is involved in the cell cycle modulation and required for effective human cytomegalovirus infection in THP-1 macrophages. Virology 2013, 440:19-30.
5. Kijpittayarit S., Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis 2007, 44:1315-1320.
6. Cervera C., Lozano F., Saval N., Gimferrer I., Ibañez A., Suárez B., et al. The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 2007, 83:1493-1500.
7. Kang S.H., Abdel-Massih R.C., Brown R.A., Dierkhising R.A., Kremers W.K., Razonable R.R. Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. J Infect Dis 2012, 205:639-646.
8. Taniguchi R., Koyano S., Suzutani T., Goishi K., Ito Y., Morioka I., et al. Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis 2013, 17:e1092-e1097.
9. Folwaczny M., Glas J., Török H.P., Limbersky O., Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol 2004, 135:330-335.
10. Paradowska E., Przepiórkiewicz M., Nowakowska D., Studzińska M., Wilczyński J., Emery V.C., et al. Detection of cytomegalovirus in human placental cells by polymerase chain reaction. APMIS 2006, 114:764-771.
11. Corr S.C., O'Neill L.A. Genetic variation in toll-like receptor signaling and the risk of inflammatory and immune diseases. J Innate Immun 2009, 1:350-357.
12. Carvalho A., Cuhna C., Carotti A., Aloisi T., Guarrera O., Di Ianni M., et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol 2009, 37:1022-1029.
13. Schröder N.W., Diterich I., Zinke A., Eckert J., Draing C., von Baehr V., et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 2005, 175:2534-2540.
14. Eid A.J., Brown R.A., Paya C.V., Razonable R.R. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007, 84:511-516.
15. Lorenz E., Mira J.P., Cornish K.L., Arbour N.C., Schwartz D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000, 68:6398-6401.
16. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004, 23:219-223.
17. Berdeli A., Celik H.A., Ozyürek R., Dogrusoz B., Aydin H.H. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med (Berl) 2005, 83:535-541.
18. Ben-Ali M., Barbouche M.R., Bousnina S., Chabbou A., Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004, 11:625-626.
19. Papadopoulous A.I., Ferwerda B., Antoniadou A., Sakka V., Galani L., Kavatha D., et al. Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection. Clin Infect Dis 2010, 51:242-247.
20. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002, 162:1028-1032.
21. Kollmann T.R., Levy O., Montgomery R.R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012, 37:771-783.
22. Hamann L., Koch A., Sur S., Hoefer N., Glaeser C., Schulz S., et al. Association of a common TLR-6 polymorphism with coronary artery disease-implications for healthy ageing?. Immun Ageing 2013, 10:43.
23. Ducloux D., Deschamps M., Yannaraki M., Ferrand C., Bamoulid J., Saas P., et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005, 67:2454-2461.
24. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596.
25. Bell J.K., Mullen G.E., Leifer C.A., Mazzoni A., Davies D.R., Segal D.M. Leucine-rich repeats and pathogen recognition in toll-like receptors. Trends Immunol 2003, 24:528-533.
26. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., et al. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007, 178:7520-7524.
27. Netea M.G., Wijmenga C., O'Neill L.A. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012, 13:535-542.
28. Mockenhaupt F.P., Cramer J.P., Hamann L., Stegemann M.S., Eckert J., Oh N.R., et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR4 variants predispose to severe malaria. Proc Natl Acad Sci U S A 2006, 103:177-182.
29. Browning B.L., Huebner C., Petermann I., Gearry R.B., Barclay M.L., Shelling A.N., et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007, 102:2504-2512.
30. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
31. Eder W., Klimecki W., Yu L., Von Mutius E., Riedler J., Braun-Fahrlander C., et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004, 113:482-488.
32. Döcke W.D., Prösch S., Fietze E., Kimel V., Zuckermann H., Klug C., et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994, 343:268-269.
33. Cook C.H., Trgovcich J., Zimmerman P.D., Zhang Y., Sedmak D.D. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 2006, 80:9151-9158.
34. Lee S.O., Brown R.A., Kang S.H., Abdel-Massih R.C., Razonable R.R. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation. Liver Transpl 2011, 17:1081-1088.
35. Texereau J., Chiche J.D., Taylor W., Choukroun G., Comba B., Mira J.P. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 2005, 41(Suppl 7):S408-S415.
36. Wang J.J., Xia X., Tang S.D., Wang J., Deng X.Z., Zhang Y., et al. Meta-analysis on the associations of TLR2 gene polymorphisms with pulmonary tuberculosis susceptibility among Asian populations. PLoS One 2013, 8:e75090.
37. Bochud P.Y., Hawn T.R., Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003, 170:3451-3454.
38. Takahashi M., Chen Z., Watanabe K., Kobayashi H., Nakajima T., Kimura A., et al. Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese. Open Dent J 2011, 5:190-194.
39. Barbalat R., Lau L., Locksley R.M., Barton G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009, 10:1200-1207.
40. Bauernfeind F., Hornung V. TLR2 joins the interferon gang. Nat Immunol 2009, 10:1139-1141.
41. Loré K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 2003, 171:4320-4328.
42. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
43. Gabrylewicz B., Mazurek U., Ochała A., Sliupkas-Dyrda E., Garbocz P., Pyrlik A., et al. Cytomegalovirus infection in acute myocardial infarction. Is there a causative relationship?. Kardiol Pol 2003, 59:283-292.
44. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Victor A., et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002, 33:2581-2586.